Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celularity Inc. - Class A Common Stock (NQ:CELU)

0.7904 -0.0216 (-2.66%)
Streaming Delayed Price Updated: 2:35 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Celularity Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Celularity (NASDAQ:CELU) shares rose 7.0% to $7.33 during Tuesday's after-market session. The market value of their outstanding shares is at $904.9... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
Via FinancialNewsMedia
News headline image
Market Briefing For Wednesday, July 21 ↗
Via Talk Markets
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
77 Biggest Movers From Yesterday ↗
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
News headline image
Analyzing Celularity's Unusual Options Activity ↗
Celularity (NASDAQ:CELU) shares experienced unusual options activity on Thursday. The stock price moved up to $10.34 following the option alert. Sentiment: BULLISH Option Type:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's... 
Via Benzinga
News headline image
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection ↗
Former PepsiCo Inc (NASDAQ: PEP) president and Apple Inc (NASDAQ: AAPL) CEO John Sculley raved about Celularity Inc (NASDAQ: CELU) Monday on Benzinga's YouTube... 
Via Benzinga
News headline image
54 Biggest Movers From Yesterday ↗
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon... 
Via Benzinga
News headline image
EXCLUSIVE: Former PepsiCo President And Apple CEO John Sculley Tells A Steve Jobs Story ↗
John Sculley, former president of PepsiCo Inc (NASDAQ: PEP) and former CEO of Apple Inc (NASDAQ: AAPL), appeared on Benzinga's YouTube show "Power... 
Via Benzinga
News headline image
30 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Cytokinetics, Incorporated (NASDAQ: CYTK) jumped 56.4% to $30.07 after the company disclosed topline results from Cohorts 1 and 2 of REDWOOD-HCM. Aehr Test Systems (... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.